EMPIND
EMPIND · NSEValuation
Blended fair value using DCF and peer comparison methods.
See if EMPIND is undervalued
Unlock intrinsic value for 4,800+ Indian stocks — free.
Sign in or create free accountThe intrinsic value shown is an algorithmic estimate based on publicly available financial data — including DCF analysis, peer comparison, and historical financials. It is not a research report, investment advice, or a recommendation to buy, sell, or hold any security. Stock valuations involve uncertainty and may differ significantly from market prices. Please consult a SEBI-registered investment adviser before making any investment decision.
Peer comparison
How this company stacks up against sector peers on valuation and quality metrics.
Diversified · 3 peers · sector medians shown
| Company | Mkt Cap | P/E | P/B | EV/EBITDA | ROE | Net Margin | Rev CAGR 3y |
|---|---|---|---|---|---|---|---|
EMPIND EMPIND · you | ₹628 Cr | 11.2× | 2.1× | — | 18.4% | 0.1% | — |
| Sector median | — | 22.2× | 1.5× | 6.2× | 13.4% | 0.1% | 5.4% |
| Lords Mark Industries Limited LORDSMARK | ₹3,754 Cr | 44.2× | 977.7× | — | 2124.1% | 0.1% | — |
| Balmer Lawrie & Company Limited BALMLAWRIE | ₹3,040 Cr | 11.0× | 1.5× | 6.2× | 13.4% | 10.2% | 5.4% |
| TTK Healthcare Limited TTKHLTCARE | ₹1,640 Cr | 22.2× | 1.6× | — | 7.1% | 0.1% | — |
EMPIND looks attractively valued — trading at a discount to sector peers on P/E (11.2× vs sector median 22.2×) while delivering above-average returns on equity (18.4% vs 13.4%).
Business quality
Valuation
Returns
Growth
Efficiency
Liquidity & Solvency
Financial health
Piotroski F-Score, Altman Z-Score, and key solvency ratios.
Full financial data
Charts and annual statements for income, balance sheet and cash flow.
Income trend
Revenue, profit and margin trends over time.
Cash flow
Where cash comes from and where it goes.
Balance sheet
Assets show what the company owns. Liabilities show what it owes. Equity is what's left for shareholders.